Hypertensive patients are at higher risk of pre-diabetes (impaired fasting glucose IFG and impaired glucose tolerance IGT) and type 2 DM. This study was done to examine whether some general, anthropometric, hormone, and metabolic parameters are different between subjects with normal and impaired glucose metabolism (IGM) in hypertensive subjects, thus possibly identifying some variable characterizing glucose metabolism derangement in these patients. A cohort of 134 hypertensive patients, 55 women and 79 men, aged 37-70 years, were examined. IGM patients were considered those showing IFG and/or IGT or type 2 DM after an oral glucose tolerance test (OGTT), and/or HbA1c > 48 mmol/l (6.5%) and/or glucose levels >155 mg/dL after 1 hour of t...
The clinical correlates and risk profile of prediabetes (fasting plasma glucose (FPG) values in the ...
We evaluated changes in glucose tolerance of 17 progressors and 62 non-progressors for 9 years to im...
We evaluated data from 10,088 participants without cardiovascular disease (CVD) who underwent 75 g o...
ObjectiveThe aim of the study was to assess of frequency and overlap of impaired glucose tolerance (...
INTRODUCTION: Obesity enhances insulin secretion and resistance. We investigated its importance in ...
Background Impaired glucose regulation (IGR) and hyperlipidemia (HL) are associated with an increase...
OBJECTIVEdIndividuals with impaired glucose tolerance (IGT) are at high risk for devel-oping type 2 ...
Reduced insulin clearance has been shown to predict the development of type 2 diabetes. Recently, it...
There is a large amount of epidemiological and clinical evidence for associations among obesity, imp...
Reduced insulin clearance has been shown to predict the development of type 2 diabetes. Recently, it...
In normoglucose-tolerant subjects (NGT), 1-h post-load plasma glucose value ≥155 mg/dL, during an or...
To analyze the clinical significance of the oral glucose tolerance test (OGTT) in the assessment of ...
Background and Aim We evaluated the relationship between insulin resistance (IR) and insulin secret...
Context: Subjects with normal glucose tolerance (NGT) but 1-h postload glucose = 155 mg/dL (NGT-1h-h...
SUMMARY Plasma glucose and insulin responses to both a 75-g oral glucose challenge and to convention...
The clinical correlates and risk profile of prediabetes (fasting plasma glucose (FPG) values in the ...
We evaluated changes in glucose tolerance of 17 progressors and 62 non-progressors for 9 years to im...
We evaluated data from 10,088 participants without cardiovascular disease (CVD) who underwent 75 g o...
ObjectiveThe aim of the study was to assess of frequency and overlap of impaired glucose tolerance (...
INTRODUCTION: Obesity enhances insulin secretion and resistance. We investigated its importance in ...
Background Impaired glucose regulation (IGR) and hyperlipidemia (HL) are associated with an increase...
OBJECTIVEdIndividuals with impaired glucose tolerance (IGT) are at high risk for devel-oping type 2 ...
Reduced insulin clearance has been shown to predict the development of type 2 diabetes. Recently, it...
There is a large amount of epidemiological and clinical evidence for associations among obesity, imp...
Reduced insulin clearance has been shown to predict the development of type 2 diabetes. Recently, it...
In normoglucose-tolerant subjects (NGT), 1-h post-load plasma glucose value ≥155 mg/dL, during an or...
To analyze the clinical significance of the oral glucose tolerance test (OGTT) in the assessment of ...
Background and Aim We evaluated the relationship between insulin resistance (IR) and insulin secret...
Context: Subjects with normal glucose tolerance (NGT) but 1-h postload glucose = 155 mg/dL (NGT-1h-h...
SUMMARY Plasma glucose and insulin responses to both a 75-g oral glucose challenge and to convention...
The clinical correlates and risk profile of prediabetes (fasting plasma glucose (FPG) values in the ...
We evaluated changes in glucose tolerance of 17 progressors and 62 non-progressors for 9 years to im...
We evaluated data from 10,088 participants without cardiovascular disease (CVD) who underwent 75 g o...